Chengdu Easton Biopharmaceuticals Co., Ltd.

Seven years of qualification Audited Supplier

Seven years of qualification Audited Supplier

Company Profile
  • Year Established: 2008
  • Total Assets(USD): choose not to disclose
  • Total Number of Staff: 450 to 499
  • Business Type: Manufacturer
  • Annual Turnover(USD) : choose not to disclose
  • Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Established in 2009 and headquartered in Chengdu High-tech district, Chengdu Easton Biopharmaceuticals Co., Ltd. is a Hi-tech pharmaceutical company, engaging in development, manufacture and distribution of commercial-scale Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Our manufacturing facilities are fully compliant with EU-GMP and US-GMP standards. Easton Biopharma has two manufacture sites and two sales companies. Formulation manufacturing site, located in Chengdu headquarter, has four Chinese cGMP-compliant production lines including Tablets, Capsules, Injection solutions and Lyophilization vials. API manufacturing site, located in Meishan, Sichuan Province, has ten CFDA approved APIs. Easton Biopharma implements innovation-driven strategy for achieving sustainable development, with focusing on continuant improvement of R&D system. We are equipped with a scientific R&D platform including QC labs, R&D center and post-doctoral center. We aim to develop and produce new and generic drugs in the fields of Diabetics, Cardiovascular, Oncology, Anesthetic, Analgesics and Biopharmaceuticals.  

Year Established: 2008

Total Assets(USD): choose not to disclose

Total Number of Staff: 450 to 499

Business Type: Manufacturer

Annual Turnover(USD) : choose not to disclose

Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Top Products
Copyright 2006-2020 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
Powered by